转载： WuXi PharmaTech Purchases an Illumina HiSeq X Ten Sequencing System# Biology - 生物学
p*h
1 楼
西红柿大赛挤进了前十，想败几个包子，猜猜俺家的石榴有多重吧，老大，老厶，总重
，猜得最相近的各一个。
，猜得最相近的各一个。
y*k
2 楼
终于有人忍不住下手了，可是到哪里找业务去喂饱这个巨兽呢
=================================================
SAN DIEGO & SHANGHAI--(BUSINESS WIRE)--Mar. 10, 2014-- Illumina, Inc. (
NASDAQ:ILMN) and WuXi PharmaTech (Cayman) Inc. (NYSE:WX), a leading
pharmaceutical, biotechnology, and medical device R&D outsourcing company
with operations in China and the United States, today announced that the
WuXi Genome Center has purchased an Illumina HiSeq X Ten sequencing system.
This new investment will enable WuXi’s clinical genomic services to expand
from the current target panel, exome, and transcriptome scale sequencing to
population genome scale sequencing. It puts the world’s most advanced gene
sequencing capability in the hands of the leading pharmaceutical R&D
services company in the Asia Pacific region.
The WuXi Genome Center meets international clinical standards and is the
only CLIA-certified clinical genomics lab in China. In addition to offering
sequencing services, WuXi’s genomics lab also provides assay development,
validation, and testing services.
“This investment in cutting-edge gene sequencing technology significantly
strengthens WuXi’s broad, integrated platform of R&D services,” said Dr.
Ge Li, Chairman and CEO of WuXi PharmaTech. “It advances our mission of
enabling anyone and any company to use our R&D platform to discover and
develop innovative medicines to benefit the world’s patients.”
The HiSeq X Ten is the world’s first platform to deliver full coverage
human genomes for $1,000, including typical instrument depreciation, DNA
extraction, library preparation, and estimated labor. Purpose-built for
population-scale human whole genome sequencing, the HiSeq X Ten can sequence
approximately 18,000 samples annually with high-quality, high-coverage
sequencing. It is sold as a set of 10 or more ultra-high throughput
sequencing systems, each generating up to 1.8 terabases (Tb) of sequencing
data in less than three days or up to 600 gigabases (Gb) per day, per system.
“We are pleased that WuXi has chosen the HiSeq X Ten to serve its clients
with state-of-the-art gene sequencing capabilities,” said Jay Flatley, CEO
of Illumina. “Illumina’s leadership in the development of genomics
technologies and WuXi’s leadership in offering high-quality R&D services to
leading biopharmaceutical companies are a perfect fit.”
About Illumina
Illumina (www.illumina.com) is a leading developer, manufacturer, and
marketer of life science tools and integrated systems for the analysis of
genetic variation and function. We provide innovative sequencing and array-
based solutions for genotyping, copy number variation analysis, methylation
studies, gene expression profiling, and low-multiplex analysis of DNA, RNA,
and protein. We also provide tools and services that are fueling advances in
consumer genomics and diagnostics. Our technology and products accelerate
genetic analysis research and its application, paving the way for molecular
medicine and ultimately transforming healthcare.
Forward-Looking Statement for Illumina
This release may contain forward-looking statements that involve risks and
uncertainties. Important factors that could cause actual results to differ
materially from those in any forward-looking statements are detailed in our
filings with the Securities and Exchange Commission, including our most
recent filings on Forms 10-K and 10-Q, or in information disclosed in public
conference calls, the date and time of which are released beforehand. We do
not intend to update any forward-looking statements after the date of this
release.
About WuXi PharmaTech
WuXi PharmaTech (www.wuxiapptec.com) is a leading pharmaceutical,
biotechnology, and medical device R&D outsourcing company, with operations
in China and the United States. As a research-driven and customer-focused
company, WuXi PharmaTech provides pharmaceutical, biotechnology, and medical
device companies with a broad and integrated portfolio of laboratory and
manufacturing services throughout the drug and medical device R&D process.
WuXi PharmaTech's services are designed to help its global partners in
shortening the cycle and lowering the cost of drug and medical device R&D.
The operating subsidiaries of WuXi PharmaTech are known as WuXi AppTec.
=================================================
SAN DIEGO & SHANGHAI--(BUSINESS WIRE)--Mar. 10, 2014-- Illumina, Inc. (
NASDAQ:ILMN) and WuXi PharmaTech (Cayman) Inc. (NYSE:WX), a leading
pharmaceutical, biotechnology, and medical device R&D outsourcing company
with operations in China and the United States, today announced that the
WuXi Genome Center has purchased an Illumina HiSeq X Ten sequencing system.
This new investment will enable WuXi’s clinical genomic services to expand
from the current target panel, exome, and transcriptome scale sequencing to
population genome scale sequencing. It puts the world’s most advanced gene
sequencing capability in the hands of the leading pharmaceutical R&D
services company in the Asia Pacific region.
The WuXi Genome Center meets international clinical standards and is the
only CLIA-certified clinical genomics lab in China. In addition to offering
sequencing services, WuXi’s genomics lab also provides assay development,
validation, and testing services.
“This investment in cutting-edge gene sequencing technology significantly
strengthens WuXi’s broad, integrated platform of R&D services,” said Dr.
Ge Li, Chairman and CEO of WuXi PharmaTech. “It advances our mission of
enabling anyone and any company to use our R&D platform to discover and
develop innovative medicines to benefit the world’s patients.”
The HiSeq X Ten is the world’s first platform to deliver full coverage
human genomes for $1,000, including typical instrument depreciation, DNA
extraction, library preparation, and estimated labor. Purpose-built for
population-scale human whole genome sequencing, the HiSeq X Ten can sequence
approximately 18,000 samples annually with high-quality, high-coverage
sequencing. It is sold as a set of 10 or more ultra-high throughput
sequencing systems, each generating up to 1.8 terabases (Tb) of sequencing
data in less than three days or up to 600 gigabases (Gb) per day, per system.
“We are pleased that WuXi has chosen the HiSeq X Ten to serve its clients
with state-of-the-art gene sequencing capabilities,” said Jay Flatley, CEO
of Illumina. “Illumina’s leadership in the development of genomics
technologies and WuXi’s leadership in offering high-quality R&D services to
leading biopharmaceutical companies are a perfect fit.”
About Illumina
Illumina (www.illumina.com) is a leading developer, manufacturer, and
marketer of life science tools and integrated systems for the analysis of
genetic variation and function. We provide innovative sequencing and array-
based solutions for genotyping, copy number variation analysis, methylation
studies, gene expression profiling, and low-multiplex analysis of DNA, RNA,
and protein. We also provide tools and services that are fueling advances in
consumer genomics and diagnostics. Our technology and products accelerate
genetic analysis research and its application, paving the way for molecular
medicine and ultimately transforming healthcare.
Forward-Looking Statement for Illumina
This release may contain forward-looking statements that involve risks and
uncertainties. Important factors that could cause actual results to differ
materially from those in any forward-looking statements are detailed in our
filings with the Securities and Exchange Commission, including our most
recent filings on Forms 10-K and 10-Q, or in information disclosed in public
conference calls, the date and time of which are released beforehand. We do
not intend to update any forward-looking statements after the date of this
release.
About WuXi PharmaTech
WuXi PharmaTech (www.wuxiapptec.com) is a leading pharmaceutical,
biotechnology, and medical device R&D outsourcing company, with operations
in China and the United States. As a research-driven and customer-focused
company, WuXi PharmaTech provides pharmaceutical, biotechnology, and medical
device companies with a broad and integrated portfolio of laboratory and
manufacturing services throughout the drug and medical device R&D process.
WuXi PharmaTech's services are designed to help its global partners in
shortening the cycle and lowering the cost of drug and medical device R&D.
The operating subsidiaries of WuXi PharmaTech are known as WuXi AppTec.
g*e
3 楼
大的450g,小的300，共750.
y*3
4 楼
好几个地方都买了啊
c*p
5 楼
大的900
小的500
小的500
a*k
6 楼
理论上一年18000，实际上能测10-15K就不错了。稍微大一点的公司就有这个量了
expand
to
gene
【在 y***k 的大作中提到】
: 终于有人忍不住下手了，可是到哪里找业务去喂饱这个巨兽呢
: =================================================
: SAN DIEGO & SHANGHAI--(BUSINESS WIRE)--Mar. 10, 2014-- Illumina, Inc. (
: NASDAQ:ILMN) and WuXi PharmaTech (Cayman) Inc. (NYSE:WX), a leading
: pharmaceutical, biotechnology, and medical device R&D outsourcing company
: with operations in China and the United States, today announced that the
: WuXi Genome Center has purchased an Illumina HiSeq X Ten sequencing system.
: This new investment will enable WuXi’s clinical genomic services to expand
: from the current target panel, exome, and transcriptome scale sequencing to
: population genome scale sequencing. It puts the world’s most advanced gene
expand
to
gene
【在 y***k 的大作中提到】
: 终于有人忍不住下手了，可是到哪里找业务去喂饱这个巨兽呢
: =================================================
: SAN DIEGO & SHANGHAI--(BUSINESS WIRE)--Mar. 10, 2014-- Illumina, Inc. (
: NASDAQ:ILMN) and WuXi PharmaTech (Cayman) Inc. (NYSE:WX), a leading
: pharmaceutical, biotechnology, and medical device R&D outsourcing company
: with operations in China and the United States, today announced that the
: WuXi Genome Center has purchased an Illumina HiSeq X Ten sequencing system.
: This new investment will enable WuXi’s clinical genomic services to expand
: from the current target panel, exome, and transcriptome scale sequencing to
: population genome scale sequencing. It puts the world’s most advanced gene
c*9
7 楼
650g
y*k
8 楼
应该是国内第一家吧。10000多个30x的基因组，他家是个CRO，自己没有项目的，科研
服务大都是零敲碎打的小单，而且这块他家也是新建的。
服务大都是零敲碎打的小单，而且这块他家也是新建的。
f*c
9 楼
老大750g，老幺400g，共1150g
t*a
10 楼
它买这个应该打算的是借国内整顿基因检测市场的机会做（易感）基因检测供货商。和
华大之类的抢生意，或者做上游。
expand
to
gene
【在 y***k 的大作中提到】
: 终于有人忍不住下手了，可是到哪里找业务去喂饱这个巨兽呢
: =================================================
: SAN DIEGO & SHANGHAI--(BUSINESS WIRE)--Mar. 10, 2014-- Illumina, Inc. (
: NASDAQ:ILMN) and WuXi PharmaTech (Cayman) Inc. (NYSE:WX), a leading
: pharmaceutical, biotechnology, and medical device R&D outsourcing company
: with operations in China and the United States, today announced that the
: WuXi Genome Center has purchased an Illumina HiSeq X Ten sequencing system.
: This new investment will enable WuXi’s clinical genomic services to expand
: from the current target panel, exome, and transcriptome scale sequencing to
: population genome scale sequencing. It puts the world’s most advanced gene
华大之类的抢生意，或者做上游。
expand
to
gene
【在 y***k 的大作中提到】
: 终于有人忍不住下手了，可是到哪里找业务去喂饱这个巨兽呢
: =================================================
: SAN DIEGO & SHANGHAI--(BUSINESS WIRE)--Mar. 10, 2014-- Illumina, Inc. (
: NASDAQ:ILMN) and WuXi PharmaTech (Cayman) Inc. (NYSE:WX), a leading
: pharmaceutical, biotechnology, and medical device R&D outsourcing company
: with operations in China and the United States, today announced that the
: WuXi Genome Center has purchased an Illumina HiSeq X Ten sequencing system.
: This new investment will enable WuXi’s clinical genomic services to expand
: from the current target panel, exome, and transcriptome scale sequencing to
: population genome scale sequencing. It puts the world’s most advanced gene
p*h
11 楼
看来这个难度不大，名次得在克上分了。不好意思写了错別字，是老幺。
老大750g，老幺400g，共1150g
【在 f*****c 的大作中提到】
: 老大750g，老幺400g，共1150g
老大750g，老幺400g，共1150g
【在 f*****c 的大作中提到】
: 老大750g，老幺400g，共1150g
G*a
12 楼
我猜大的500G 小的200G，因为我们家大小是这样。
p*h
13 楼
西红柿大赛挤进了前十，想败几个包子，猜猜俺家的石榴有多重吧，老大，老厶，总重
，猜得最相近的各一个。
，猜得最相近的各一个。
g*e
14 楼
大的450g,小的300，共750.
c*p
15 楼
大的900
小的500
小的500
c*9
16 楼
650g
f*c
17 楼
老大750g，老幺400g，共1150g
p*h
18 楼
看来这个难度不大，名次得在克上分了。不好意思写了错別字，是老幺。
老大750g，老幺400g，共1150g
【在 f*****c 的大作中提到】
: 老大750g，老幺400g，共1150g
老大750g，老幺400g，共1150g
【在 f*****c 的大作中提到】
: 老大750g，老幺400g，共1150g
G*a
19 楼
我猜大的500G 小的200G，因为我们家大小是这样。
p*h
20 楼
两个都得大点儿。
我猜大的500G 小的200G，因为我们家大小是这样。
【在 G********a 的大作中提到】
: 我猜大的500G 小的200G，因为我们家大小是这样。
我猜大的500G 小的200G，因为我们家大小是这样。
【在 G********a 的大作中提到】
: 我猜大的500G 小的200G，因为我们家大小是这样。
y*8
21 楼
大的550g, 小的250g?
两个都得大点儿。
我猜大的500G 小的200G，因为我们家大小是这样。
【在 p******h 的大作中提到】
: 两个都得大点儿。
:
: 我猜大的500G 小的200G，因为我们家大小是这样。
两个都得大点儿。
我猜大的500G 小的200G，因为我们家大小是这样。
【在 p******h 的大作中提到】
: 两个都得大点儿。
:
: 我猜大的500G 小的200G，因为我们家大小是这样。
x*2
22 楼
大的620g, 小的150g
p*h
23 楼
小看了咱南加的阳光？
大的620g, 小的150g
【在 x******2 的大作中提到】
: 大的620g, 小的150g
大的620g, 小的150g
【在 x******2 的大作中提到】
: 大的620g, 小的150g
m*i
24 楼
大735 幺390 共1125
p*y
25 楼
大的480 小的320
【在 g***e 的大作中提到】
: 大的450g,小的300，共750.
【在 g***e 的大作中提到】
: 大的450g,小的300，共750.
L*3
26 楼
大的600g,小的300g
T*4
27 楼
大的400克，小的30克，总共430
m*6
28 楼
捣乱来的？
【在 T*******4 的大作中提到】
: 大的400克，小的30克，总共430
【在 T*******4 的大作中提到】
: 大的400克，小的30克，总共430
T*4
29 楼
说不定我最准呢
【在 m**6 的大作中提到】
: 捣乱来的？
【在 m**6 的大作中提到】
: 捣乱来的？
m*6
30 楼
楼上有hint了，回去重猜~~~
【在 T*******4 的大作中提到】
: 说不定我最准呢
【在 T*******4 的大作中提到】
: 说不定我最准呢
l*d
31 楼
大的850g，小的400g，共1250跟。
L*a
32 楼
785g. 285g. 1070g
G*a
33 楼
重新猜，大的930，小的560，总共1490克
p*h
34 楼
小的少了个零。
大的400克，小的30克，总共430
【在 T*******4 的大作中提到】
: 大的400克，小的30克，总共430
大的400克，小的30克，总共430
【在 T*******4 的大作中提到】
: 大的400克，小的30克，总共430
p*h
35 楼
谁蠃了自己知道，明天发包子。
重新猜，大的930，小的560，总共1490克
【在 G********a 的大作中提到】
: 重新猜，大的930，小的560，总共1490克
重新猜，大的930，小的560，总共1490克
【在 G********a 的大作中提到】
: 重新猜，大的930，小的560，总共1490克
L*a
36 楼
小的是我猜赢了耶，只差了7g。
y*2
37 楼
又是一刀准，下次俺就跟在Lauren妈后面了😄
【在 L******a 的大作中提到】
: 小的是我猜赢了耶，只差了7g。
【在 L******a 的大作中提到】
: 小的是我猜赢了耶，只差了7g。
T*m
38 楼
大的800克，小的600克。
f*a
39 楼
迟了
【在 T*******m 的大作中提到】
: 大的800克，小的600克。
【在 T*******m 的大作中提到】
: 大的800克，小的600克。
f*c
40 楼
那得给个纠错包子才行。吼吼
【在 p******h 的大作中提到】
: 看来这个难度不大，名次得在克上分了。不好意思写了错別字，是老幺。
:
: 老大750g，老幺400g，共1150g
【在 p******h 的大作中提到】
: 看来这个难度不大，名次得在克上分了。不好意思写了错別字，是老幺。
:
: 老大750g，老幺400g，共1150g
p*h
41 楼
赢了两项涅，总重也是你。
【在 L******a 的大作中提到】
: 小的是我猜赢了耶，只差了7g。
【在 L******a 的大作中提到】
: 小的是我猜赢了耶，只差了7g。
p*h
42 楼
没问题， 双黄， 还赢了老大。
【在 f*****c 的大作中提到】
: 那得给个纠错包子才行。吼吼
【在 f*****c 的大作中提到】
: 那得给个纠错包子才行。吼吼
p*h
43 楼
LaurenMa猜中了老幺和总重， 梦想猜中了老大。小高妈妈得最认真奖，Pink最接近奖
， 小四好像应该给我个包子，LOL.
【在 p******h 的大作中提到】
: 西红柿大赛挤进了前十，想败几个包子，猜猜俺家的石榴有多重吧，老大，老厶，总重
: ，猜得最相近的各一个。
， 小四好像应该给我个包子，LOL.
【在 p******h 的大作中提到】
: 西红柿大赛挤进了前十，想败几个包子，猜猜俺家的石榴有多重吧，老大，老厶，总重
: ，猜得最相近的各一个。
f*c
44 楼
谢双黄包
【在 p******h 的大作中提到】
: LaurenMa猜中了老幺和总重， 梦想猜中了老大。小高妈妈得最认真奖，Pink最接近奖
: ， 小四好像应该给我个包子，LOL.
【在 p******h 的大作中提到】
: LaurenMa猜中了老幺和总重， 梦想猜中了老大。小高妈妈得最认真奖，Pink最接近奖
: ， 小四好像应该给我个包子，LOL.
T*4
45 楼
我请人猜重量的时候，如果没有特别申明，一般会发一个最离谱奖
【在 p******h 的大作中提到】
: LaurenMa猜中了老幺和总重， 梦想猜中了老大。小高妈妈得最认真奖，Pink最接近奖
: ， 小四好像应该给我个包子，LOL.
【在 p******h 的大作中提到】
: LaurenMa猜中了老幺和总重， 梦想猜中了老大。小高妈妈得最认真奖，Pink最接近奖
: ， 小四好像应该给我个包子，LOL.
L*3
46 楼
谢谢包子
G*a
47 楼
谢谢啦啊！
【在 p******h 的大作中提到】
: 西红柿大赛挤进了前十，想败几个包子，猜猜俺家的石榴有多重吧，老大，老厶，总重
: ，猜得最相近的各一个。
【在 p******h 的大作中提到】
: 西红柿大赛挤进了前十，想败几个包子，猜猜俺家的石榴有多重吧，老大，老厶，总重
: ，猜得最相近的各一个。
L*a
48 楼
谢谢双黄，好开心啊！
p*h
49 楼
没错儿，上次俺就得了一个，不过鼓励小得离谱好对于发扬正能量班风无补。这样吧，
俺发你一个，你发我，个双黃，就扯平了。晚上回家发。
俺发你一个，你发我，个双黃，就扯平了。晚上回家发。
相关阅读